Swiss National Bank - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 127 filers reported holding G1 THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 4.45 and the average weighting 0.1%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$248,168
-55.8%
92,600
-10.5%
0.00%
Q4 2022$562,005
+5.0%
103,500
+47.0%
0.00%
Q1 2022$535,000
-18.8%
70,400
+9.1%
0.00%
Q4 2021$659,000
-23.9%
64,5000.0%0.00%
-100.0%
Q3 2021$866,000
-38.8%
64,5000.0%0.00%0.0%
Q2 2021$1,415,000
-8.8%
64,5000.0%0.00%0.0%
Q1 2021$1,552,000
+33.8%
64,5000.0%0.00%0.0%
Q4 2020$1,160,000
+59.1%
64,500
+2.2%
0.00%0.0%
Q3 2020$729,000
-52.4%
63,1000.0%0.00%0.0%
Q2 2020$1,531,000
+172.4%
63,100
+23.7%
0.00%0.0%
Q1 2020$562,000
-57.6%
51,000
+1.6%
0.00%0.0%
Q4 2019$1,327,000
+18.7%
50,200
+2.2%
0.00%0.0%
Q3 2019$1,118,000
-24.7%
49,100
+1.4%
0.00%
-50.0%
Q2 2019$1,484,000
+102.7%
48,400
+9.8%
0.00%
+100.0%
Q1 2019$732,000
-0.4%
44,100
+14.8%
0.00%0.0%
Q4 2018$735,000
-62.1%
38,400
+3.5%
0.00%
-50.0%
Q3 2018$1,940,000
+25.7%
37,100
+4.5%
0.00%0.0%
Q2 2018$1,543,000
+17.3%
35,5000.0%0.00%0.0%
Q1 2018$1,315,000
+359.8%
35,500
+146.5%
0.00%
Q4 2017$286,00014,4000.00%
Other shareholders
G1 THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 994,287$19,041,0001.55%
HHLR ADVISORS, LTD. 949,431$18,182,0000.75%
BB BIOTECH AG 671,925$12,867,0000.41%
Rhenman & Partners Asset Management AB 172,820$3,310,0000.38%
Birchview Capital, LP 15,000$287,0000.27%
Rock Springs Capital Management LP 100,000$1,915,0000.09%
SECOR Capital Advisors, LP 32,591$624,0000.08%
MARSHALL WACE, LLP 386,510$7,402,0000.08%
SIGNATUREFD, LLC 37,942$727,0000.07%
A.R.T. Advisors, LLC 38,125$730,0000.05%
View complete list of G1 THERAPEUTICS INC shareholders